Abstract
Amniotic fluid C-peptide (AFCP), insulin, and glucose levels were measured in 33 diabetic and 126 nondiabetic pregnant women at ≖36 weeks' gestation. Levels of AFCP distinguished diabetic from nondiabetic patients more reliably than amniotic fluid (AF) insulin or glucose. Levels of AFCP in diabetic patients correlated well with Infant birth weight adjusted for gestational ages(large for gestational age > adequate for gestational age), degree of diabetic control (fair to poor control > good control), or diabetogenic infant morbidity, but did not correlate, with classes of diabetes within the limits of the population studied. We conclude that AFCP is a usefull prognostic index tor predicting fetal outcome in diabetic pregnancies. A level of AFCP of ≖1.0 pmoles/ml is associated with an increased risk of macrosomia in infants of diabetic mothers. (Am. J. Obstet. Gynecol. 141:671, 1981.)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
